Sarissa Capital Management as of June 30, 2014
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 15 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 26.0 | $76M | 12M | 6.37 | |
| Idenix Pharmaceuticals | 16.4 | $48M | 2.0M | 24.10 | |
| Quest Diagnostics Incorporated (DGX) | 15.5 | $46M | 775k | 58.69 | |
| Bio-Reference Laboratories | 13.2 | $39M | 1.3M | 30.22 | |
| Merck & Co (MRK) | 7.9 | $23M | 400k | 57.85 | |
| Repros Therapeutics | 5.9 | $17M | 1.0M | 17.30 | |
| Vivus | 4.7 | $14M | 2.6M | 5.32 | |
| Amgen (AMGN) | 1.8 | $5.3M | 45k | 118.38 | |
| AVEO Pharmaceuticals | 1.6 | $4.7M | 2.6M | 1.83 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $4.5M | 105k | 43.07 | |
| Kindred Biosciences | 1.4 | $4.3M | 228k | 18.64 | |
| Laboratory Corp. of America Holdings (LH) | 1.3 | $3.9M | 38k | 102.40 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $3.6M | 215k | 16.86 | |
| Targacept | 1.0 | $2.8M | 630k | 4.51 | |
| Onconova Therapeutics | 0.7 | $1.9M | 350k | 5.43 |
